A first-in-human phase 1 trial of dose escalating intrathecal (IT) dendritic cells (cDC1s) primed against HER2/HER3 in patients (pts) with leptomeningeal disease (LMD) from triple-negative (TNBC) or HER2+ breast cancer (BC)
Abstract
TPS2090 Background: Leptomeningeal disease (LMD) is a devastating complication of BC where it occurs in approximately 5% of pts and has a dismal prognosis. The CSF of pts with LMD have an innate (PMID:34035069), but not adaptive, immune response (bioRxiv 2023.03.17.533041; doi: https://doi.org/10.1101/2023.03.17.533041) that is insufficient to combat LMD. We used IT cDC1 to elicit an adaptive response in murine LMD and found that IT cDC1s were safe, induced a Th1 response, cured most HER2+ LMD, and prevented LMD recurrence (PMCID: 9354231). This Th1 response was CD4+ > CD8+ T cell dependent and produced marked B cell infiltration in the CSF. Mechanistic studies are in progress. These cDC1s have been shown to induce Th1 responses to HER2 and HER3 tumors and prolong survival in preclinical models (PMID: 35710296; PMID: 34785506). And there are several trials of cDC1s in BC patients that are ongoing (NCT03384914, NCT03387553, NCT05504707, NCT05325632, NCT04348747, NCT05378464). On the basis of our murine studies we hypothesized testing cDC1 therapy in pts that a RP2D would be found and the CSF following cDC1 therapy would be remodeled to have a Th1 adaptive immunological profile. Methods: This is a phase I single-arm, non-randomized dose escalation multicenter study to establish 1) the safety of IT cDC1s in pts with LMD, and 2) associations between clinical outcomes & translational CSF studies such as scRNAseq and cytokine/chemokine arrays. Eligibility includes TNBC or HER+ LMD…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- In silico strategies for modeling RNA aptamers and predicting binding sites of their molecular targets
- Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery
- Anti-phytopathogenic and plant growth promoting potential of endophytic fungi isolated from Dysoxylum gotadhora
- Mercury toxicity causes iron and sulfur deficiencies along with oxidative injuries in alfalfa (Medicago sativa)
- Suppression of lncRNA GAS6-AS2 alleviates sepsis-related acute kidney injury through regulating the miR-136-5p/OXSR1 axis in vitro and in vivo
- Assessing the Protective Effect of Moringa oleifera Extract against Bone Metastasis: An In Vitro Simulated Digestion Approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.